The Human Microbiome: Advancing New Frontiers in a Rapidly Emerging Market

NEEDHAM, MA--(Marketwired - May 17, 2016) - Insight Pharma Reports, a division of Healthtech Publishing, offers additional coverages on the human microbiome with a second report, "The Human Microbiome: Advancing New Frontiers in a Rapidly Emerging Market," which focuses on biomedical aspects of research, development, and commercial endeavors in the human microbiome space. It includes essential background information, evolution of the field, advances in basic research, events in the emerging commercial market, deal activity, interviews with experts, and trends in microbiome research and commerce.

The Human Microbiome: Advancing New Frontiers in a Rapidly Emerging Market report covers:

• Advances in Research on the Human Microbiome
• Commercial Aspects of Microbiome Research and Development
• Current Deal Activity
• Over 25 Companies Profiled
• Survey data from exclusive Insight Pharma Reports Survey

Exclusive to this report are interviews with:

• Lee Jones, Founder CEO, Rebiotix
• Brian Varnum, PhD, Chief Development Officer C3 Jian
• Yanjiao Zhou, MD, PhD, Research Scientist, The Jackson Laboratory for Genomic Medicine
• Dr Bernard Malfroy-Camine, President and CEO, ViThera Pharmaceuticals
• Mark L. Heiman, Ph.D., FTOS, Vice President, Research and CSO, MicroBiome Therapeutics (formerly NuMe Health)
• Larry Weiss, MD, Chief Medical Officer, AOBiome, LLC
• Karen E. Nelson, PhD, President, J. Craig Venter Institute (JCVI), Head, Microbiome Program, Human Longevity Institute (HLI)
• Sara Malcus, PhD, CEO, MetaboGen AB

For more information The Human Microbiome: Advancing New Frontiers in a Rapidly Emerging Market, visit: www.insightpharmareports.com/Human-Microbiome-2016-Report.

About Insight Pharma Reports (www.insightpharmareports.com)

Insight Pharma Reports, a division of Healthtech Publishing, is the premier life sciences information provider offering unparalleled coverage of key issues in drug discovery and development. The reports are used by leading pharmaceutical, biotech, diagnostic, and other life science companies to keep abreast of the latest developments in pharmaceutical R&D and their potential applications and business impacts. The reports are written by experts in consulting and industry, and are supported by hundreds of hours of primary and secondary research. Insight Pharma Reports provide comprehensive coverage of salient issues in a concise, well-organized format.

About Healthtech Publishing (www.healthtechpublishing.com)

Healthtech Publishing, a division of Cambridge Healthtech Institute, provides the life science communities with business critical intelligence through research reports and digital news, helping decision makers to gain competitive advantage and make strategic decisions. Our portfolio consists of Insight Pharma Reports' vast research reports collection and three niche digital subscription products: Bio-IT World, Clinical Informatics News and Diagnostics World.